Abstrait
Les cancers sans primitif connu regroupent les cancers présentant des métastases sans que le site primitif soit découvert après examen clinique, examens biologiques, radiologiques et/ou endoscopiques au moment du choix thérapeutique (4). Ils représentent de 3 à 10 % de tous les cancers (9, 12). Une atteinte du squelette est retrouvée chez 10 à 15 % d’entre eux (5, 7, 12, 15). La plus grande partie de ces cancers sont des carcinomes sans primitif connu. La médiane de survie est de 6 à 12 mois (1, 15).
Références
Abbruzzesse JL, Abbruzzesse MC, Lenzi R et al. (1995) Analysis of a diagnostic strategy for patients with suspected tumors of unknown origin. J Clin Oncol 13: 2094–103
Alacalay M, Azais I, Brigeon B et al. (1995) Strategy for identifying primary malignancies with inaugural bone metastases. Rev Rhum Engl Ed 62: 632–42
Brage ME, Simon MA (1992) Evaluation, prognosis, and medical treatment considerations of metastatic bone tumors. Orthopedics 15: 589–96
Daugaard G (1994) Unknown primary tumors. Cancer Treat Rev 20: 119–47
Didolkar MS, Fanous N, Elias G et al. (1977) Metastatic carcinomas from occult primary tumors. Ann Surg 86: 625–30
Hainsworth JD, Greco FA (1993) Treatment of patients with cancer of an unknown primary site. N Engl J Med 329: 257–63
Holmes FF, Fouts TL (1970) Metastatic cancer of unknown primary site. Cancer 26: 816–20
Karavasilis V, Malamou-Mitsi V, Briasoulis E, Tsanou E, Kitsou E, Kalafonos H, Fountzilas G, Fotsis T, Pavlidis N (2005) Angiogenesis in cancer of unknown primary: clinicopathological study of CD34, VEGF and TSP-1. BMC Cancer 5: 25
Karsell PR, Sheeny PF, O’Connell M (1982) Computed tomography in search of cancer of unknown origin. JAMA 248: 340–3
Le Cesne A, Le Chevalier T, Caille P et al. (1991) Métastases de cancers à point de départ inconnu. Enseignement de 302 autopsies. Presse Méd 20: 1369–73
Mayordomo JL, Guerra JM, Guijarro C et al. (1993) Neoplasms of unknown primary site: a clinico-pathological study of autopsied patients. Tumori 79: 321–4
Moertel CG, Reitmeier RJ, Schutt AJ et al. (1972) Treatment of the patient with adenocarcinoma of unknown origin. Cancer 30: 1469–72
Rades, Kuhnel G, Wildfang I, Borner AR, Schmoll HJ, Knapp W (2001) Localised disease in cancer of unknown primary (CUP): the value of positron emission tomography for individual therapeutic management. Ann Oncol 12: 1605–9
Rougraff BT, Kneisl JS, Simon MA (1993) Skeletal metastases of unknown origin. A prospective study of a diagnostic strategy. J Bone Joint Surg Am 75: 1276–81
Stewart JF, Tattersall MH, Woods RL et al. (1979) Unknown primary adenocarcinoma: incidence of overinvestigation and natural history. Br Med J 1: 1530–3
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2007 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Ravaud, A. (2007). Métastases vertébrales des cancers sans primitif connu. In: Pointillart, V., Ravaud, A., Palussière, J. (eds) Métastases vertébrales. Springer, Paris. https://doi.org/10.1007/978-2-287-33744-4_20
Download citation
DOI: https://doi.org/10.1007/978-2-287-33744-4_20
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-33743-7
Online ISBN: 978-2-287-33744-4